Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells.
Apart from their role as antigen presenting cells, human peripheral blood monocyte and CD34+ cell-derived dendritic cells (DC), have been demonstrated to exert cytotoxicity against some tumor cells, and their tumoricidal activity can be enhanced by some stimili. However, there have been no reports concerning the tumoricidal activity of human cord blood dendritic cells (CBDC). In this article, we report that human cord blood monocyte-derived DC acquire the ability to kill hematological tumor cells, after activation with lipopolysaccharide (LPS) or gamma-interferon (IFN-gamma), associated with the enhanced TNF-alpha-related apoptosis-inducing ligand (TRAIL) expression in CBDC cytoplasm. The CD14-positive cells collected from cord blood were induced to CBDC in vitro. After activation with IFN-gamma for 12 h, CBDC exhibited cytotoxicity against HL60 and Jurkat cells, while activation with LPS induced cytotoxicity against Daudi and Jurkat cells. However, both LPS- and IFN-gamma-stimulated CBDC showed no cytotoxic activity against normal CD14-negative cord blood mononuclear cells. The formation of umbilical cord hematopoietic progenitor colonies, identified as burst-forming unit-erythroid and colony-forming unit granulocyte-macrophage, was not inhibited by stimulated or unstimulated CBDC. IFN-gamma or LPS stimulation enhanced intracellular but not cellular surface TRAIL, and neither intracellular nor cellular surface tumor necrosing factor-alpha and Fas Ligand as analyzed by flow cytometry. Our results show that activated CBDC can serve as cytotoxic cells against hematological tumor cells without damaging the normal hematopoietic progenitor cells.
Shi
Jun
J
Hematology Department, Sixth Hospital of Shanghai Jiaotong University, Shanghai 200233, China.
Ikeda
Kazuma
K
Fujii
Nobuharu
N
Kondo
Eisei
E
Shinagawa
Katsuji
K
Ishimaru
Fumihiko
F
Kaneda
Kinuyo
K
Tanimoto
Mitsune
M
Li
Xiao
X
Pu
Quan
Q
D018952:Antigens, CD34 / Q000378:metabolism; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D016667:Bacterial Capsules; D003114:Colony-Forming Units Assay; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology*; D005312:Fetal Blood; D018922:HL-60 Cells; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D019169:Jurkat Cells; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology; D053221:TNF-Related Apoptosis-Inducing Ligand; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D018952:Antigens, CD34; D051017:Apoptosis Regulatory Proteins; D018950:Lipopolysaccharide Receptors; D008562:Membrane Glycoproteins; D011135:Polysaccharides, Bacterial; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; C110031:capsular polysaccharide 35A; D007371:Interferon-gamma
J Exp Med. 1994 Jul 1;180(1):83-93
8006603
J Immunol. 2000 Oct 15;165(8):4202-8
11035052
Oncol Rep. 2004 May;11(5):1017-23
15069541
Eur J Immunol. 1997 Dec;27(12):3135-42
9464798
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4930-4
7515183
J Exp Med. 1999 Oct 18;190(8):1155-64
10523613
J Immunol. 1996 Aug 1;157(3):1117-26
8757616
J Exp Med. 1993 Feb 1;177(2):295-304
8381152
Br J Haematol. 2001 Apr;113(1):240-6
11328307
J Immunol. 2001 May 1;166(9):5407-15
11313377
J Immunol. 2001 Oct 1;167(7):3765-72
11564793
Eur J Immunol. 1997 Feb;27(2):431-41
9045914
Stem Cells Dev. 2004 Feb;13(1):63-70
15068694
Blood. 2000 Apr 1;95(7):2346-51
10733505
J Exp Med. 1999 Apr 19;189(8):1343-54
10209050
J Immunol. 2002 Feb 15;168(4):1831-9
11823516
J Immunol. 1997 Jun 15;158(12):5676-84
9190916
J Immunol. 2001 Oct 1;167(7):3565-9
11564767
J Immunol. 2002 Feb 15;168(4):1823-30
11823515
Annu Rev Immunol. 1991;9:271-96
1910679
J Immunol. 1998 Dec 1;161(11):6238-44
9834111
J Biol Chem. 1996 May 31;271(22):12687-90
8663110
Blood. 1996 Feb 15;87(4):1292-302
8608217
Clin Cancer Res. 2000 Mar;6(3):829-37
10741704
Cell Immunol. 1997 Oct 10;181(1):59-67
9344497
J Immunol. 1999 Aug 15;163(4):1906-13
10438925
J Virol. 2000 Jan;74(1):556-9
10590149
J Immunol. 1999 Jan 1;162(1):168-75
9886383
J Immunol. 1999 Nov 15;163(10):5358-66
10553060